Not finding it? Sign in to also search OpenAlex live.
-
THU0375 IMPROVEMENTS IN GLOBAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH UPADACITINIB: RESULTS FROM THE SELECT-AXIS 1 TRIAL2020 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Uta Kiltz, Joachim Sieper, Atul A. Deodhar, Patrick Zueger, In‐Ho Song, Nanxin Chen, +1 more
1citations -
POS0798 EFFICACY, SAFETY AND RADIOGRAPHIC OUTCOMES FROM THE PHASE 3 SELECT-AXIS 2 STUDY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: 2-YEAR DATA2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
X. Baraliakos, D. van der Heijde, J. Sieper, Robert Davies Inman, H. Kameda, Walter P. Maksymowych, +5 more
1citations -
POS0924 PREDICTORS OF 1-YEAR TREATMENT RESPONSE AMONG UPADACITINIB-TREATED PATIENTS WITH ANKYLOSING SPONDYLITIS: A POST HOC ANALYSIS OF SELECT-AXIS 12021 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Marina Magrey, Sofía Ramiro, Marcelo M. Pinheiro, Fabiana Ganz, In‐Ho Song, Ana Biljan, +2 more
1citations -
POS0050 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 SELECT-AXIS 2 STUDY2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
Filip E Van den Bosch, Atul A. Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, T.-H. Kim, +7 more
0citations -
P491 Efficacy and safety outcomes of long-term treatment with filgotinib 200 mg among patients with Ulcerative Colitis: An interim analysis of SELECTIONLTE2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
B G Feagan Senior Scientific Officer, Katsuyoshi Matsuoka, Gerhard Rogler, Margaux Faes, Alessandra Faria Oortwijn, C Rudolph, +2 more
5citations -
POS0433 COMPARISON OF MUSCULOSKELETAL REFERRAL PATHWAYS ACROSS EUROPE2025 Annals of the Rheumatic Diseases conference-abstract Business, Management and Accounting Healthcare Systems and Technology Open access
Georgy Gomon, Maxime Raffray, Inés Pérez-Sancristóbal, S. Curiel - Manzanas, Elena Polentinos-Castro, Luis Rodríguez‐Rodríguez, +4 more
0citations -
OP35 Efficacy and safety outcomes up to ~4 years of treatment with filgotinib 200 mg among patients with Ulcerative Colitis: Results from the SELECTIONLTE study2023 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
B G Feagan, Gerhard Rogler, Margaux Faes, Alessandra Faria Oortwijn, C Rudolph, Laurent Peyrin‐Biroulet
3citations -
P46 Efficacy and safety of long-term treatment with filgotinib for ulcerative colitis: data from SELECTIONLTE2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Brian G. Feagan, Katsuyoshi Matsuoka, Gerhard Rogler, Margaux Faes, Alessandra Faria Oortwijn, +4 more
1citations -
P678 Long-term efficacy, safety and health-related quality of life in patients who achieved comprehensive disease control with filgotinib in SELECTION: analysis of ~3 years in SELECTIONLTE2024 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
B G Feagan Senior Scientific Officer, Katsuyoshi Matsuoka, Gerhard Rogler, David Laharie, Severine A.R.A. Vermeire, Silvio Danese, +8 more
0citations -
POS1325 UNLOCKING THE POTENTIAL OF LIPIDOMICS FOR PREDICTIVE TREATMENT STRATEGIES IN PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Mieke L M Bentvelzen, Yuhong Zhang, Amy C. Harms, H.E. Vonkeman, Shasti C. Mooij, Lydia G. Schipper, +3 more
0citations -
PB1431 Effect of Allele-Selective Silencing of von Willebrand Factor in Mice on Experimental Bleeding and Thrombosis Models2023 Research and Practice in Thrombosis and Haemostasis conference-abstract Medicine Platelet Disorders and Treatments Open access
Yvonne K. Jongejan, Noa A. Linthorst, Richard J. Dirven, Bas van Vlijmen, Cécile V. Denis, Jeroen C.J. Eikenboom
0citations -
PB1436 PAR1 Knockout Induced Pluripotent Stem Cell-Derived Vascular Smooth Muscle Cells Display Higher Tissue Factor-Dependent Thrombin Generation Compared to Wild Type0citations
-
P517 Re-treatment with filgotinib in patients with Ulcerative Colitis following treatment interruption: Analysis of the SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Gerhard Rogler
2citations -
P133 In vitro pharmacological profile of GLPG3667 suggests differentiation from the TYK2 inhibitors deucravacitinib and TAK-279 at their clinical dose regimens2024 Journal of Crohn s and Colitis conference-abstract Medicine Cytokine Signaling Pathways and Interactions Open access
Willem Hettema, Patrick Nolain, Isabelle Parent, Roland Blanqué, Laetitia Furio, Lucia Angella, +1 more
1citations -
P47 Re-treatment with filgotinib in patients with ulcerative colitis following treatment interruption: SELECTION and SELECTIONLTE data2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Severine Vermiere, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, +2 more
0citations